Rare diseases
Investigational molecules
Locations
1600 Sierra Point Parkway, 94005-1809, United States
Nurix Therapeutics Inc. focuses on clinical research in relapsed/refractory B-cell malignancies, with particular attention to chronic lymphocytic leukemia and small lymphocytic lymphoma.
The sponsor’s active trials are directed toward patients with disease that has progressed after prior treatment, reflecting a strong therapeutic interest in difficult-to-treat blood cancers.
Nurix Therapeutics Inc. runs clinical trials in conditions such as Chronic lymphocytic leukaemia, Chronic lymphocytic leukaemia refractory, Chronic lymphocytic leukaemia recurrent, B-cell small lymphocytic lymphoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
